Correlation Between Delcath Systems and INVO Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Delcath Systems and INVO Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delcath Systems and INVO Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Delcath Systems and INVO Bioscience, you can compare the effects of market volatilities on Delcath Systems and INVO Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delcath Systems with a short position of INVO Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delcath Systems and INVO Bioscience.

Diversification Opportunities for Delcath Systems and INVO Bioscience

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Delcath and INVO is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Delcath Systems and INVO Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INVO Bioscience and Delcath Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delcath Systems are associated (or correlated) with INVO Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INVO Bioscience has no effect on the direction of Delcath Systems i.e., Delcath Systems and INVO Bioscience go up and down completely randomly.

Pair Corralation between Delcath Systems and INVO Bioscience

Given the investment horizon of 90 days Delcath Systems is expected to generate 0.35 times more return on investment than INVO Bioscience. However, Delcath Systems is 2.88 times less risky than INVO Bioscience. It trades about 0.14 of its potential returns per unit of risk. INVO Bioscience is currently generating about 0.01 per unit of risk. If you would invest  275.00  in Delcath Systems on August 26, 2024 and sell it today you would earn a total of  701.00  from holding Delcath Systems or generate 254.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy96.79%
ValuesDaily Returns

Delcath Systems  vs.  INVO Bioscience

 Performance 
       Timeline  
Delcath Systems 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Delcath Systems are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Delcath Systems may actually be approaching a critical reversion point that can send shares even higher in December 2024.
INVO Bioscience 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days INVO Bioscience has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very weak basic indicators, INVO Bioscience displayed solid returns over the last few months and may actually be approaching a breakup point.

Delcath Systems and INVO Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Delcath Systems and INVO Bioscience

The main advantage of trading using opposite Delcath Systems and INVO Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delcath Systems position performs unexpectedly, INVO Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INVO Bioscience will offset losses from the drop in INVO Bioscience's long position.
The idea behind Delcath Systems and INVO Bioscience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity